TA stock exchange 224 88.
(photo credit: Bloomberg)
The TA-25 Index advanced 0.7 percent, the biggest gain since April 14, to 1,208.54 at the close in Tel Aviv on Sunday. Investors traded about NIS 1.46 billion in shares and convertible securities.
Bio Light Israeli Life Sciences advanced 10% after its Zetiq Technologies unit signed an agreement with China’s Biomics Biotechnologies to cooperate in conducting clinical tests.
D-Pharm, a biopharmaceutical company, retreated 1.2% after saying it
was weighing the possibility of raising NIS 23 million to fund the
development of a treatment for migraines, epilepsy and bipolar disorder.
Delek Group, an energy and real-estate holding company, rose 1.7% after
its Delek US Holdings unit was rated new “sector perform” at RBC
Micromedic Technologies, a biomedical development company, climbed 5.2%
after saying it had begun testing its kit for the early diagnosis of
colon cancer to receive CE Mark approval to market the product in
Procognia Israel, a developer of tools for analyzing sugars in
proteins, surged 19% after saying the first trial in a joint research
project with Seahorse Bioscience Inc. had been successful.